HALIFAX, NS / ACCESSWIRE / / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended ...
HALIFAX, NS / ACCESSWIRE / December 30, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2024. During Q1 FY2025, MedMira has been ...
GlobalData on MSN12d
Health Canada approves MedMira’s rapid test for HIV and syphilisThe test enables healthcare professionals to identify HIV-1/2 and syphilis antibodies from a single finger prick sample.
HALIFAX, NS / ACCESSWIRE / December 30, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2024.Corporate updateDuring Q1 FY2025, MedMi ...
HALIFAX, NS / ACCESSWIRE / December 30, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2024. Corporate update During Q1 FY2025 ...
Medmira (TSE:MIR) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall Street analysts, ...
During Q1 FY2025, MedMira has been continuing its regulatory work and clinical trials for its Reveal® G4 HIV-1/2 rapid test CLIA-waiver and with it made substantial progress on its FDA ...
all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter MedMira Inc. has reported significant progress in its regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback